Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SNCA , a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis

25 Jan 2018

Abstract excerpt

Medulloblastoma (MB) is the most common malignant brain tumor in childhood. It contains at least four distinct molecular subgroups. The aim of this study is to explore novel diagnostic and potential therapeutic markers within each subgroup of MB, in particular within Group 4, the largest subgroup, to facilitate diagnosis together with gene therapy. One hundred and six MB samples were examined. Tumor subtype was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Glioma Diagnosis and Treatment
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29369502
DOI: 10.1111/cas.13515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SNCA , a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosisPMID 29369502Read ↗

Signaling pathway and molecular subgroups of medulloblastoma.Semantic proximity Read ↗

Molecular subgroups of medulloblastoma: the current consensusSemantic proximity Read ↗

Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.Semantic proximity Read ↗

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma TreatmentSemantic proximity Read ↗

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical PracticeSemantic proximity Read ↗

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic InsightsSemantic proximity Read ↗

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroupsSemantic proximity Read ↗

Medulloblastoma genomics in the modern molecular eraSemantic proximity Read ↗

New Approaches in Targeted Therapy for Medulloblastoma in ChildrenSemantic proximity Read ↗

Reproducibility of the NanoString 22‐gene molecular subgroup assay for improved prognostic prediction of medulloblastomaSemantic proximity Read ↗

Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.Semantic proximity Read ↗

Medulloblastoma in the age of molecular subgroups: a reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.